• Introduction
  • Why Almac?
  • People
  • Facilities
• Biomarker Discovery and Validation
  • Companion Diagnostics
  • Pharmacodynamic Biomarkers
  • Prognostic tests
  • Drug Repositioning
  • Consultancy
• Bioinformatics Solutions
  • Gene Selection
  • Signature generation
  • Functional analysis
• Genomic services
  • Gene Expression and SNP analysis
  • qPCR and cell line modelling
  • Bioinformatics
• Proprietary Discovery Arrays
  • Unique Content
  • Work with FFPE and fresh frozen tissue
  • Discover Targets, signatures and answers
• Resources
  • Technical Documentation
  • Posters and presentations
  • Publications

Consultancy

In addition to our expertise in biomarker discovery, bioinformatics and genomic services, we have extensive knowledge in:

• Clinical trial design
• Regulatory requirements
• Molecular biology
• Molecular oncology

We offer a full consultancy service and we will work with customers to find the solution for their requirements. We are the first company to approach the FDA with a FFPE based microarray test. We have experience of regulatory requirements and can also provide guidance in routes on regulatory approval.

We also have considerable expertise in using conventional generic microarrays for profiling FFPE tumors where a disease specific DSA^® platform has not yet been developed.